Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 6-month OTC-simulated, Open Label, Uncontrolled Study of Tamsulosin 0.4 mg in Men

NCT02573311 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT02573311
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02573311 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 6-month OTC-simulated, Open Label, Uncontrolled Study of Tamsulosin 0.4 mg in Men
Lead sponsor
Boehringer Ingelheim
Phase
Phase 3
Overall status
Completed
Start date
September 23, 2015
Completion date
August 1, 2016
Enrollment
1,117 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

urological manifestations